Subscribe To

Price Alert Latest News Economic Calendar News

NXGN / NextGen Healthcare Sees Higher Growth Ahead Amid Operating Improvements

NextGen Healthcare, Inc. provides a range of managed software and service solutions to the U.S. healthcare industry. Management has guided fiscal 2024 revenue growth slightly higher than the previous year, and operating profits are growing. I'm cautiously optimistic on the firm's prospects now that the false claims settlement is quantified, so my outlook for NextGen Healthcare stock is a Buy at around $17.00 per share. Read More

Demo Live Account See Partner Details

Content Topics

Nextgen

Healthcare

Sees

Higher

Growth

Ahead

Amid

Operating

Improvements

Stock

NXGN

Posted: Jul 18 2023, 17:02

Author Name: Seeking Alpha

NXGN News

By Zacks Investment Research
October 25, 2023

NextGen (NXGN) Q2 Earnings Top Estimates, Margins Down

NextGen's (NXGN) second-quarter fiscal 2024 results reflect strength in its Recurring revenues.

By Zacks Investment Research
October 24, 2023

Here's What Key Metrics Tell Us About Nextgen Healthcare (NXGN) Q2 Earnings

Although the revenue and EPS for Nextgen Healthcare (NXGN) give a sense of how its business performed in the quarter ended September 2023, it might be

By Zacks Investment Research
October 24, 2023

Nextgen Healthcare (NXGN) Surpasses Q2 Earnings and Revenue Estimates

Nextgen Healthcare (NXGN) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares

By Zacks Investment Research
October 11, 2023

NextGen's (NXGN) AI-Based Ambient Assist to Expedite Care Plans

NextGen's (NXGN) Ambient Assist will help reduce significant time by summarizing appointments and preparing care plans using AI-driven technology in r

By Zacks Investment Research
September 26, 2023

NextGen (NXGN) Extends Agreement to Boost Athletico's Footprint

NextGen's (NXGN) latest extended agreement is likely to reflect its solutions' potential to aid healthcare organizations at all stages of growth.

By CNBC Television
September 7, 2023

Healthcare tech is great for longterm buyout fundamental investing, says Thoma's Orlando Bravo

Orlando Bravo, Thoma Bravo founder and managing partner, joins 'Squawk on the Street' to discuss the state of the private equity market, the deal to b

By Investopedia
September 6, 2023

Private Equity Firm Thoma Bravo Acquires NextGen Healthcare for $1.6 Billion

NextGen Healthcare Inc. (NXGN), an Atlanta, GA-based healthcare data provider, has agreed to be acquired by private equity firm Thoma Bravo in a deal

By The Motley Fool
September 6, 2023

Why Shares of NextGen Healthcare Are Rising Wednesday

NextGen's stock was down 79% this year. The buyout would be worth $1.6 billion.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.